Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Classical hematology 1CNS 1

Conditions

Leukemia, Myeloid, Acute 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Myelodysplastic Syndromes 9Lymphoma, Non-Hodgkin 7Leukemia 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Hematologic Neoplasms 5Congenital Abnormalities 4Breast Neoplasms 4Neuroblastoma 3Leukemia, Myeloid, Accelerated Phase 3Leukemia, Lymphocytic, Chronic, B-Cell 3Hodgkin Disease 3Blast Crisis 3Anemia, Refractory, with Excess of Blasts 3Wilms Tumor 2Testicular Neoplasms 2Sarcoma 2Rhabdomyosarcoma 2Retinoblastoma 2Ovarian Neoplasms 2Neuroectodermal Tumors, Primitive, Peripheral 2Medulloblastoma 2Liver Neoplasms 2Kidney Neoplasms 2Hepatoblastoma 2Graft vs Host Disease 2Desmoplastic Small Round Cell Tumor 2Central Nervous System Neoplasms 2Astrocytoma 2

Interventions

fludarabine phosphate 2Whole-Body Irradiation 2Therapeutics 2Cyclophosphamide 2thymoglobulin 1fosphenytoin 1fludarabine 1Thiotepa 1Phenytoin 1Peripheral Blood Stem Cell Transplantation 1Melphalan 1Busulfan 1Antilymphocyte Serum 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Immunologic Deficiency Syndromes × Thiotepa × Clear all
NCT00801931 2019-03-27

Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders

Columbia University

Phase 1/2 Terminated
1 enrolled 8 charts
CNSClassical hematologyLymphoidOther hematologic neoplasm

Anemia, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡